Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Published online before print November 2, 2006, doi:10.1212/01.wnl.0000247740.47667.03)
This Article
Right arrow Full Text (Rapid PDF)
Right arrow CME: Take the course for this article:
 Volume 68, Number 5, January 30, 2007
Right arrow Data Supplement
Right arrow All Versions of this Article:
01.wnl.0000247740.47667.03v1
68/5/384    most recent
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dorsey, E. R.
Right arrow Articles by Tanner, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dorsey, E. R.
Right arrow Articles by Tanner, C. M.
Received February 20, 2006
Accepted August 28, 2006

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030

E. R. Dorsey MD, MBA*, R. Constantinescu MD, J. P. Thompson BA, K. M. Biglan MD, MPH, R. G. Holloway MD, MPH, K. Kieburtz MD, MPH, F. J. Marshall MD, B. M. Ravina MD, MSCE, G. Schifitto MD, A. Siderowf MD, MSCE, and C. M. Tanner MD, PhD

From the Department of Neurology (E.R.D., R.C., K.M.B., R.G.H., K.K., F.J.M., B.M.R., G.S.), University of Rochester Medical Center, and School of Public Health (J.P.T.), University of Rochester, NY, Department of Neurology (A.S.), University of Pennsylvania Medical Center, Philadelphia, PA, and Parkinson’s Institute (C.M.T.), Sunnyvale, CA. R.C. is currently with the Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.


* To whom correspondence should be addressed. E-mail: ray.dorsey{at}ctcc.rochester.edu.

Abstract-- Based on published prevalence studies, we used two different methodologies to project the number of individuals with Parkinson disease (PD) in Western Europe’s 5 most and the world’s 10 most populous nations. The number of individuals with PD over age 50 in these countries was between 4.1 and 4.6 million in 2005 and will double to between 8.7 and 9.3 million by 2030.




This article has been cited by other articles:


Home page
 NeurologyHome page
C. Marras and A. Lang
Invited Article: Changing concepts in Parkinson disease: Moving beyond the Decade of the Brain
Neurology, May 20, 2008; 70(21): 1996 - 2003.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. M. Albert
Projecting neurologic disease burden: Difficult but critical
Neurology, January 30, 2007; 68(5): 322 - 323.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
Vincent P. Calabrese, MD, FAAN (senior)
Neurology Online, 1 Apr 2007 [Full text]
Reply from the Authors
E. Ray Dorsey, et al.
Neurology Online, 1 Apr 2007 [Full text]

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by AAN Enterprises, Inc.